The use of pharmaceuticals to treat Major Depressive Disorder (MDD) has several drawbacks, including severe side effects. Natural compounds with great efficacy and few side effects are in high demand due to the global rise in MDD and ineffective treatment. Yohimbine, a natural compound, has been used to treat various ailments, including neurological conditions, since ancient times. Serotonergic neurotransmission plays a crucial role in the pathogenesis of depression; thus, serotonergic receptor agonist/antagonistic drugs are promising anti-depressants. Yohimbine was investigated in this study to determine its antidepressant activity using molecular docking and pharmacokinetic analyses. Additionally, the in silico mutational study was carried out to understand the increase in therapeutic efficiency using site-directed mutagenesis. Conformational changes and fluctuations occurring during wild type and mutant serotonergic receptor, 5-hydroxytryptamine receptors 1A (5HT1A) and yohimbine were assessed by molecular dynamics MD simulation studies. Yohimbine was found to satisfy all the parameters for drug-likeness and pharmacokinetics analysis. It was found to possess a good dock score and hydrogen-bond interactions with wild type 5HT1A structure. Our findings elaborate the substantial efficacy of yohimbine against MDD; however, further bench work studies may be carried out to prove the same.

Chromium is a toxic heavy metal abundantly present in the environment, specifically in groundwater. The groundwater in Saudi Arabia was assessed for heavy metal presence; chromium was detected at a high concentration in Madinah. Many researchers have used various bioprocesses over the last few decades to mitigate Cr(VI) toxicity. The genus Pseudomonas member Pseudomonas putida is widely dispersed in the natural environment. P. putida is chromate-resistant and has a high chromate reduction rate. Bioremediation procedures can eradicate the most potently toxic metal, Cr(VI), in water, air, and soil. Chromate reductase (ChrR) is a bacterial enzyme from P. putida that can be utilized in bioremediation to remove chromate from the environment in a cost-effective and environmentally safe approach. To comprehend the role of ChrR in reducing Cr(VI) to Cr(III), a thorough sequence analysis was followed by constructing models for wild-type and mutants by applying several homology modeling techniques. The protein structure quality of the generated models was evaluated, and the best model was adopted for further optimization by employing an energy minimization technique. Molecular docking studies investigated the intra-molecular interaction between wild-type and mutant ChrR and Cr(VI). Our study is a novel method for determining the 3D structure and interaction of ChrR with Cr(VI) to convert it to a less hazardous form (III). Additionally, it provides stable mutants: Arg83Trp, Gly124Ile, and His127Trp, with a high binding affinity for Cr(VI), which can be considered for protein engineering to produce stable and efficacious enzymes to reduce Cr(VI) to a less toxic form.

In Saudi Arabia, seawater desalination is the primary source of acquiring freshwater, and groundwater contains a high concentration of toxic heavy metals. Chromium (Cr) is one of the heavy metals that is widely distributed in the environment, particularly in the groundwater of Madinah. Diverse techniques are employed to eliminate the toxicity of heavy metals from the environment, but, lately, the focus has shifted to biological remediation systems, due to their higher removal efficiencies, lower costs, and more ecologically benign characteristics than the conventional methods. Providencia bacteria engage in a variety of adsorption processes to interact with heavy metals. In this study, we aim to investigate the role of potential active site residues in the bioengineering of chromate reductase (ChrR) from Providencia alcalifaciens to reduce the Cr to a lesser toxic form by employing robust computational approaches. This study highlights Cr bioremediation by providing high-quality homology-modeled structures of wild type and mutants and key residues of ChrR for bioengineering to reduce the Cr toxicity in the environment. Glu79 is found to be a key residue for Cr binding. The mutant models of Arg82Cys, Gln126Trp, and Glu144Trp are observed to establish more metallic interactions within the binding pocket of ChrR. In addition, the wild type ChrR (P. alcalifaciens) has been found to be unstable. However, the mutations stabilized the structure by preserving the metallic contacts between the critical amino acid residues of the identified motifs and the Cr(VI). Therefore, the mutants discovered in the study can be taken into account for protein engineering to create reliable and effective enzymes to convert Cr(VI) into a lesser toxic form.

No abstract